Targeting the Wnt/ββ-catenin signaling pathway in human cancers

被引：169
作者：
Yao, Hisayuki [1 ]
Ashihara, Eishi [1 ,2 ]
Maekawa, Taira [1 ]
机构：
[1] Kyoto Univ Hosp, Dept Transfus Med & Cell Therapy, Sakyo Ku, Kyoto 6068507, Japan
[2] Kyoto Prefectural Univ Med, Dept Mol Cell Physiol, Kamigyo Ku, Kyoto 6028566, Japan
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2011年 / 15卷 / 07期
关键词：
cancer; cancer stem cell; high-throughput screening; Wnt; beta-catenin; FREQUENT EPIGENETIC INACTIVATION; SMALL-MOLECULE ANTAGONISTS; FRIZZLED-RELATED PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; INHIBITORY FACTOR-I; F-BOX PROTEIN; COLORECTAL-CANCER; WNT PATHWAY; STEM-CELLS; PROMOTER HYPERMETHYLATION;
D O I：
10.1517/14728222.2011.577418
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Areas covered: This review discusses the potential of inhibiting the Wnt/beta beta-catenin signaling pathway, as a therapeutic approach for cancer, along with an overview of the development of specific inhibitors. Expert opinion: Cancer stem cells (CSCs) play a significant role in the development and recurrence of several cancers, and Wnt/beta beta-catenin signaling is important for the proliferation of CSCs. Inhibition of Wnt/beta beta-catenin signaling is therefore a promising treatment approach. Progress has been made in the development of screening methods to identify Wnt/beta beta-catenin signaling inhibitors. Biomarker-based screening is an effective and promising method for the identification of compounds of interest.
引用
收藏
页码：873 / 887
页数：15
相关论文
共 132 条
  • [1] Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer
    Aguilera, O.
    Fraga, M. F.
    Ballestar, E.
    Paz, M. F.
    Herranz, M.
    Espada, J.
    Garcia, J. M.
    Munoz, A.
    Esteller, M.
    Gonzalez-Sancho, J. M.
    [J]. ONCOGENE, 2006, 25 (29) : 4116 - 4121
  • [2] Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer
    Ai, Lingbao
    Tao, Qian
    Zhong, Sheng
    Fields, C. Robert
    Kim, Wan-Ju
    Lee, Michael W.
    Cui, Yan
    Brown, Kevin D.
    Robertson, Keith D.
    [J]. CARCINOGENESIS, 2006, 27 (07) : 1341 - 1348
  • [3] Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma
    Akiri, G.
    Cherian, M. M.
    Vijayakumar, S.
    Liu, G.
    Bafico, A.
    Aaronson, S. A.
    [J]. ONCOGENE, 2009, 28 (21) : 2163 - 2172
  • [4] Axin-mediated CKI phosphorylation of β-catenin at Ser 45:: a molecular switch for the Wnt pathway
    Amit, S
    Hatzubai, A
    Birman, Y
    Andersen, JS
    Ben-Shushan, E
    Mann, M
    Ben-Neriah, Y
    Alkalay, I
    [J]. GENES & DEVELOPMENT, 2002, 16 (09) : 1066 - 1076
  • [5] Future Prospect of RNA Interference for Cancer Therapies
    Ashihara, Eishi
    Kawata, Eri
    Maekawa, Taira
    [J]. CURRENT DRUG TARGETS, 2010, 11 (03) : 345 - 360
  • [6] β-Catenin Small Interfering RNA Successfully Suppressed Progression of Multiple Myeloma in a Mouse Model
    Ashihara, Eishi
    Kawata, Eri
    Nakagawa, Yoko
    Shimazaski, Chihiro
    Kuroda, Junya
    Taniguchi, Kyoko
    Uchiyama, Hitoji
    Tanaka, Ruriko
    Yokota, Asumi
    Takeuchi, Miki
    Kamitsuji, Yuri
    Inaba, Tohru
    Taniwaki, Masafumi
    Kimura, Shinya
    Maekawa, Taira
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (08) : 2731 - 2738
  • [7] Mining the Wnt pathway for cancer therapeutics
    Barker, Nick
    Clevers, Hans
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) : 997 - 1014
  • [8] Linking colorectal cancer to Wnt signaling
    Bienz, M
    Clevers, H
    [J]. CELL, 2000, 103 (02) : 311 - 320
  • [9] Gene expression profiling in the discovery, optimization and development of novel drugs: one universal screening platform
    Bol, D
    Ebner, R
    [J]. PHARMACOGENOMICS, 2006, 7 (02) : 227 - 235
  • [10] Sulindac targets nuclear β-catenin accumulation and Wnt signalling in adenomas of patients with familial adenomatous polyposis and in human colorectal cancer cell lines
    Boon, EMJ
    Keller, JJ
    Wormhoudt, TAM
    Giardiello, FM
    Offerhaus, GJA
    van der Neut, R
    Pals, ST
    [J]. BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 224 - 229
12345678910